20.11.2013 Views

Guidelines for Metals and Metalloids in Ambient ... - ARCHIVE: Defra

Guidelines for Metals and Metalloids in Ambient ... - ARCHIVE: Defra

Guidelines for Metals and Metalloids in Ambient ... - ARCHIVE: Defra

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Expert Panel on Air Quality St<strong>and</strong>ards<br />

Figure 2.2: Arsenic – pulmonary absorption, metabolism, tissue distribution <strong>and</strong><br />

excretion. (a) 30-60% <strong>in</strong>haled arsenic present <strong>in</strong> most respirable particulate matter is<br />

deposited <strong>in</strong> the lung. (b) Particulate matter deposit onto the airway surface <strong>and</strong> the<br />

soluble <strong>for</strong>ms if arsenic move <strong>in</strong>to the airway fluid. (c) Pentavalent arsenic is reduced<br />

to trivalent arsenic <strong>in</strong> the blood. (d) Trivalent arsenic is taken up by the liver <strong>and</strong><br />

metabolised to monomethylarsonic acid <strong>and</strong> dimethylars<strong>in</strong>ic acid. (e)<br />

monomethylarsonic acid <strong>and</strong> dimethylars<strong>in</strong>ic acid are elim<strong>in</strong>ated from the liver <strong>and</strong><br />

excreted by the kidney (f) The majority of <strong>in</strong>haled arsenic is excreted by the kidney.<br />

a<br />

As<br />

As 5+<br />

As 3+<br />

c<br />

b<br />

As<br />

As 3+ As 3+<br />

Liver<br />

Methylation<br />

d<br />

MMA + DMA<br />

Tissue distribution<br />

e<br />

f<br />

Excretion (75%)<br />

Pentavalent arsenic tends to be elim<strong>in</strong>ated rapidly. It is largely (50–70%) reduced <strong>in</strong><br />

the blood to the trivalent <strong>for</strong>m, part of which is methylated <strong>in</strong> the liver (Marafante<br />

et al., 1985; Vahter <strong>and</strong> Marafante, 1985). The efficiency of methylation decreases<br />

with <strong>in</strong>creas<strong>in</strong>g dose level <strong>and</strong> with low prote<strong>in</strong> <strong>in</strong>take (Vahter <strong>and</strong> Marafante, 1987).<br />

22

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!